Trademark: 90520756
Status Date
Wednesday, February 8, 2023
Filing Date
Tuesday, February 9, 2021
Published for Opposition
Tuesday, November 9, 2021
Abandoned Date
Monday, January 30, 2023
5 Therapeutic pharmaceutical for the treatment of infectious disease, including COVID-19
42 Research and development in the pharmaceutical and biotechnology fields relating to infectious disease, including COVID -19; pharmaceutical research and development relating to infectious disease, including COVID -19; scientific research and development relating to infectious disease, including COVID -19
Feb 8, 2023
Abandonment Notice E-Mailed - Failure To Respond
Feb 8, 2023
Abandonment Notice Mailed - Failure To Respond
Feb 8, 2023
Abandonment - Failure To Respond Or Late Response
Jul 27, 2022
Notification Of Non-Final Action E-Mailed
Jul 27, 2022
Non-Final Action E-Mailed
Jul 27, 2022
Su - Non-Final Action - Written
Jun 28, 2022
Statement Of Use Processing Complete
Jun 1, 2022
Use Amendment Filed
Jun 17, 2022
Case Assigned To Intent To Use Paralegal
Jun 1, 2022
Teas Statement Of Use Received
Jan 4, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 9, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 9, 2021
Published For Opposition
Oct 20, 2021
Notification Of Notice Of Publication E-Mailed
Oct 1, 2021
Approved For Pub - Principal Register
Sep 9, 2021
Examiner's Amendment Entered
Sep 9, 2021
Notification Of Examiners Amendment E-Mailed
Sep 9, 2021
Examiners Amendment E-Mailed
Sep 9, 2021
Examiners Amendment -Written
Sep 2, 2021
Assigned To Examiner
May 14, 2021
New Application Office Supplied Data Entered
Feb 12, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
